Dupilumab 1
DUPILUMAB*
DUPILUMAB*
CEMIPLIMAB*
REGN1979
REGN3767*
CEMIPLIMAB + REGN1979
CEMIPLIMAB + REGN3767*
REGN3470-3471-3479
REGN3048-3051
REGN2477 + TREVOGRUMAB
REGN3500 + DUPILUMAB*
REGN1908-1909
REGN3918
EVINACUMAB
DUPILUMAB*
SARILUMAB*
CEMIPLIMAB*
REGN2477
REGN3500*
ALIROCUMAB*
DUPILUMAB*
EVINACUMAB
AFLIBERCEPT
FASINUMAB†
CEMIPLIMAB*
* in collaboration with Sanofi
† in collaboration with Teva and Mitsubishi Tanabe
This graphic displays pipeline drug candidates currently undergoing clinical testing in a variety of diseases. The safety and efficacy of these drug candidates have not been fully evaluated by any regulatory authorities for the indications described in this section.